KROS Operating Cash Flow Growth

Keros Therapeutics Inc · Operating Cash Flow Growth

KROS logo

KROS Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-187.20%
KROS TTM Cash from Operations YoY % (-130.62% → -187.20%)
High-resolution chart · PNG

KROS operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Keros Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-187.1966%
-227.491%
166.8277%
163.2761%
138.2749%
133.2723%
-29.2037%
-16.4559%
-29.4208%
-31.0713%
-77.7112%
-76.7159%
-91.4965%
-93.8383%
-12.7341%
-34.8203%
-23.4821%
-35.1104%
-68.4502%
-47.0132%
-77.317%
-81.8051%
-130.6163%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.